Pluri Inc. Earnings Per Share (Basic)
Pluri Inc. (PLUR) reported Earnings Per Share (Basic) of -$2.44 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-10
- Pluri Inc. earnings per share, basic for the quarter ending 2026-06-30 was $38.57, a 37.43% decline year-over-year.
- Pluri Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.55.
- Pluri Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.71.
- Pluri Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.65.
- Pluri Inc. earnings per share, basic for fiscal 2026 was -$2.44.
- Pluri Inc. earnings per share, basic for fiscal 2025 was -$3.56.
- Pluri Inc. earnings per share, basic for fiscal 2024 was -$3.99.
- Pluri Inc. earnings per share, basic for fiscal 2023 was -$6.24.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $38.57 derived: net income ÷ weighted average shares · filed 2026-09-10 | $1009.26 derived: net income ÷ weighted average shares · filed 2026-09-10 | $1946.84 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$2.44 10-K · filed 2026-09-10 | ||||
| 2026-03-31 | -$0.55 10-Q · filed 2026-05-14 | $1972.91 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.90 10-Q · filed 2026-05-14 | $3050.88 derived: net income ÷ weighted average shares · filed 2026-09-10 | ||||
| 2025-12-31 | -$0.71 10-Q · filed 2026-02-12 | -$1.36 10-Q · filed 2026-02-12 | $2013.56 derived: net income ÷ weighted average shares · filed 2026-09-10 | $2949.05 derived: net income ÷ weighted average shares · filed 2026-09-10 | ||||
| 2025-09-30 | -$0.65 10-Q · filed 2025-11-12 | $1010.06 derived: net income ÷ weighted average shares · filed 2026-09-10 | $1932.20 derived: net income ÷ weighted average shares · filed 2026-09-10 | $2849.33 derived: net income ÷ weighted average shares · filed 2026-09-10 | ||||
| 2025-06-30 | $61.64 derived: net income ÷ weighted average shares · filed 2026-09-10 | $981.75 derived: net income ÷ weighted average shares · filed 2026-09-10 | $1898.33 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$3.56 10-K · filed 2026-09-10 | ||||
| 2025-03-31 | -$0.94 10-Q · filed 2026-05-14 | $1998.51 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$2.56 10-Q · filed 2026-05-14 | |||||
| 2024-12-31 | -$0.53 10-Q · filed 2026-02-12 | -$1.61 10-Q · filed 2026-02-12 | ||||||
| 2024-09-30 | -$1.08 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | -$3.99 10-K · filed 2025-09-17 | |||||||
| 2024-03-31 | -$1.01 10-Q · filed 2025-05-13 | -$2.92 10-Q · filed 2025-05-13 | ||||||
| 2023-12-31 | -$0.96 10-Q · filed 2025-02-11 | -$0.12 10-Q · filed 2024-02-12 | -$1.92 10-Q · filed 2025-02-11 | -$0.24 10-Q · filed 2024-02-12 | ||||
| 2023-09-30 | -$0.96 10-Q · filed 2024-11-12 | -$0.12 10-Q · filed 2023-11-13 | ||||||
| 2023-06-30 | -$6.24 10-K · filed 2024-09-18 | -$0.78 10-K · filed 2023-09-12 | ||||||
| 2023-03-31 | -$1.52 10-Q · filed 2024-05-09 | -$0.19 10-Q · filed 2023-05-09 | -$5.04 10-Q · filed 2024-05-09 | -$0.63 10-Q · filed 2023-05-09 | ||||
| 2022-12-31 | -$0.24 10-Q · filed 2024-02-12 | -$0.44 10-Q · filed 2024-02-12 | ||||||
| 2022-09-30 | -$0.19 10-Q · filed 2023-11-13 | |||||||
| 2022-06-30 | -$1.28 10-K · filed 2023-09-12 | |||||||
| 2022-03-31 | -$0.31 10-Q · filed 2023-05-09 | -$1.00 10-Q · filed 2023-05-09 | ||||||
| 2021-12-31 | -$0.34 10-Q · filed 2023-02-13 | -$0.70 10-Q · filed 2023-02-13 | ||||||
| 2021-09-30 | -$0.36 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | -$1.77 10-K · filed 2022-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |